Nordion Reports Second Quarter Fiscal 2014 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of products and services to the global health science market, today reported results for the second quarter of fiscal 2014. The Company generated $74.7 million in revenue for the second quarter of fiscal 2014, an increase of $18.6 million, or 33%, from revenue of $56.1 million for the same period in fiscal 2013. The 2014 fiscal year financial outlook remains as previously announced on April 24, 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC